Startup Funding Strategy: Grants, Angels, VCs & Partnerships

Strategy for startup entrepreneurs. By Raymond Chan

In research-based entrepreneurship, the challenge is rarely the existence of brilliant ideas. It’s deciding how to fund the journey from early proof to real adoption.

Early stage ventures often need capital for far more than engineering: validating customer demand, building prototypes, meeting regulatory or safety requirements, protecting IP and running iterative trials that can take longer than traditional investors expect. Because of this, the best funding source depends on stage, risk profile and the specific milestones the company must reach next.

A strong capital strategy matches each type of investor or funding program to a distinct purpose. This can include stretching the runway, de-risking technology and accelerating go-to-market strategy, while preventing early dilution or distractions.

The Right Money for the Right Milestones

A common mistake is treating funding as a single event rather than a sequence of milestone-driven needs. In reality, early ventures move through different stages: technical feasibility, product-market fit signals, early commercialization,and scaling. Each state attracts different funding types.

Grants are often best when the goal is to reduce technical uncertainty, build early prototypes, or support research activities that contribute to public or scientific value. They can also buy time while teams validate assumptions that investors are not yet ready to underwrite.
Angels are typically stronger when the company needs early validation and believes the team can execute quickly – especially when there is compelling initial evidence (e.g., prototypes, pilot interest, early IP defensibility).
Venture capitalists usually become more relevant when the venture can demonstrate credible traction, expanding market potential and a pathway to scalable business outcomes.
Strategic partnerships or even mergers and acquisitions can provide resources beyond cash – access to distribution, domain expertise, co-development capabilities, pilot customers, or credibility in regulated or complex markets. Most importantly, it can be an exit strategy for founders and early investors who wish to be rewarded for their patience.

When founders align funding to the next set of measurable milestones, capital becomes a tool for progress rather than a tradeoff that forces premature scaling.

Curiosity Meets Capital

Research-based startups often have two simultaneous stories: the scientific narrative and the commercial narrative. Investors don’t fund experiments – they fund the likelihood of converting experiments into repeatable outcomes. That means your capital plan must explain what will be learned at each stage and how those learnings reduce risk.

For example, early proof may be a lab result or a technical prototype. But funding readiness improves when you can answer questions such as:

Who will pay and why?
What problem is urgent enough to create willingness to adopt?
How long is the path from prototype to deployment?
What evidence supports feasibility and differentiation?
What milestones will be completed with the next tranche of funding?

A well-designed strategy makes it easier for each funding source to see where they fit – and why the next step matters.

Building a Plan Investors can Believe

A practical capital strategy should include three elements:

Stage-aligned funding mix (what you will use – grants versus angels versus venture capital versus partners – and why)
Milestone map (what you will complete with each funding source)
Runway logic (how long you can operate and what happens if milestones slip)

Investors are ultimately assessing whether your plan converts uncertainty into certainty over time. The strongest founders design their fundraising as part of execution – not as a periodic scramble.

Conclusion

Raising capital in research-based entrepreneurship is most effective when it is treated as a strategic system rather than a single fundraising event. Grants, angels, venture capitalists and strategic partnerships each play a distinct role – de-risking research, proving market signals, scaling adoption and accelerating credibility.
When founders match funding sources to the right milestones and communicate progress in a way investors can measure, capital becomes a force multiplier. The result is not just a better chance to raise money but also a clearer route to building ventures that genuinely solve real problems and create long-term positive impact.

ABOUT RAYMOND CHAN
Raymond is a software engineer by profession with a track record in corporate innovation and entrepreneurship. He co-founded two prosperous startups, TGG Interactive and Global Gaming Group in USA and Asia respectively, where he served as director and CEO to lead the electronic gaming businesses from 2007 to 2018. Earlier in his career, Raymond was a founding member of the business intelligence team at ETRADE from Morgan Stanley and played a pivotal role in designing the TiVo customer intelligence system in Silicon Valley.